Dyslipidemia clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
Sorry, in progress, not accepting new patients
Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).
Irvine, California and other locations
Our lead scientists for Dyslipidemia research studies include Ailin Barseghian Elfarra.
Last updated: